- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.05. | Vaccine void means current Ebola outbreak declared international emergency | ||
| 18.05. | Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup | ||
| 18.05. | Japan's MHLW approves Boehringer's Jascayd for IPF and PPF | ||
| 18.05. | FDA approves Enhertu for two HER2-positive early breast cancer indications | ||
| 15.05. | Nonprofits join forces to debut marketplace for shelved CGTs | ||
| 15.05. | Arna Pharma and Slate Run complete JV for new US company | ||
| 15.05. | Biopharma industry endorses Pazdur for FDA commissioner role | ||
| 15.05. | Kyowa Kirin secures FDA approval for Crysvita dosing update | ||
| 14.05. | UK health secretary Wes Streeting resigns | ||
| 14.05. | Coya Therapeutics secures FDA fast track status for COYA 302 | ||
| 14.05. | Regulatory round-up: A month of key FDA approvals for cancer drugs | ||
| 14.05. | Imfinzi set to become first immunotherapy for stomach cancer patients on NHS | ||
| 14.05. | Zydus to acquire Assertio in $166m deal | ||
| 14.05. | Pfizer receives EC approval for Hympavzi to treat haemophilia | ||
| 13.05. | EU advances plans to reduce reliance on drug imports | ||
| 13.05. | UAE approves AstraZeneca's Baxfendy for hypertension | ||
| 13.05. | Isomorphic Labs receives $2.1bn for AI drug development | ||
| 12.05. | Makary resigns, with Diamantas named as acting FDA commissioner | ||
| 12.05. | BMS and Hengrui forge $15.2bn alliance for early-stage drugs | ||
| 12.05. | FDA weighs drug repurposing pathway for underserved diseases | ||
| 12.05. | BridgeBio's Attruby challenges Pfizer's Vyndamax legacy in pivotal ATTR trial | ||
| 12.05. | GSK and SBP Group team up to advance bepirovirsen launch in China | ||
| 12.05. | Partner Therapeutics secures FDA approval for Bizengri | ||
| 11.05. | Cellular Intelligence licenses Novo's shelved Parkinson's cell therapy programme | ||
| 11.05. | FDA locks down post-approval pregnancy safety data framework |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.